These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8289992

  • 1. Effects of erythropoietin on trace elements in patients with chronic renal failure undergoing hemodialysis.
    Hosokawa S, Yoshida O.
    Nephron; 1993; 65(3):414-7. PubMed ID: 8289992
    [Abstract] [Full Text] [Related]

  • 2. Trace elements and complications in patients undergoing chronic hemodialysis.
    Hosokawa S, Oyamaguchi A, Yoshida O.
    Nephron; 1990; 55(4):375-9. PubMed ID: 2392189
    [Abstract] [Full Text] [Related]

  • 3. Effect of erythropoietin (rHuEPO) on trace elements and quality of life (Qol) in chronic hemodialysis patients.
    Hosokawa S, Yoshida O.
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):415-21. PubMed ID: 7981926
    [Abstract] [Full Text] [Related]

  • 4. Effect of recombinant human erythropoietin (rHuEPO) on protein, zinc (Zn), nickel (Ni) and manganese (Mn) in patients undergoing chronic haemodialysis.
    Hosokawa S, Yoshida O.
    Int Urol Nephrol; 1995 Aug; 27(2):207-14. PubMed ID: 7591581
    [Abstract] [Full Text] [Related]

  • 5. Trace metals and anemia in chronic hemodialysis patients.
    Hosokawa S, Nishitani H, Tomoyoshi T, Yoshida O.
    ASAIO Trans; 1986 Aug; 32(1):305-8. PubMed ID: 3778727
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical studies on renal function and trace elements].
    Hosokawa S, Morinaga M, Yoshida O.
    Hinyokika Kiyo; 1988 Jan; 34(1):46-51. PubMed ID: 3376804
    [Abstract] [Full Text] [Related]

  • 7. Long-term changes in trace elements in patients undergoing chronic hemodialysis.
    Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF.
    Biol Trace Elem Res; 2006 Feb; 109(2):115-21. PubMed ID: 16444001
    [Abstract] [Full Text] [Related]

  • 8. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
    Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, Higuchi T, Soma M.
    Nutrients; 2015 May 15; 7(5):3783-95. PubMed ID: 25988769
    [Abstract] [Full Text] [Related]

  • 9. Variation of trace element concentrations in patients undergoing hemodialysis in the north of Spain.
    Gómez de Oña C, Martínez-Morillo E, Gago González E, Vidau Argüelles P, Fernández Merayo C, Álvarez Menéndez FV.
    Scand J Clin Lab Invest; 2016 Oct 15; 76(6):492-9. PubMed ID: 27362816
    [Abstract] [Full Text] [Related]

  • 10. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease.
    Muirhead N, Churchill DN, Goldstein M, Nadler SP, Posen G, Wong C, Slaughter D, Laplante P.
    Am J Nephrol; 1992 Oct 15; 12(5):303-10. PubMed ID: 1488998
    [Abstract] [Full Text] [Related]

  • 11. Relationship between erythropoietin and trace elements.
    Hosokawa S, Oyamaguchi A, Yoshida O.
    Contrib Nephrol; 1991 Oct 15; 93():261-3. PubMed ID: 1802594
    [No Abstract] [Full Text] [Related]

  • 12. Trace element levels in patients with renal failure and after transplantation.
    Danielson BG, Fellström B, Nilsson P, Weiss L, Wikström B.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct 15; 59 Suppl 7():438-41. PubMed ID: 3535377
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT, Prata MM, Barbas JV, dos Santos JP.
    Acta Med Port; 1990 Oct 15; 3(6):347-52. PubMed ID: 2089856
    [Abstract] [Full Text] [Related]

  • 14. Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
    Lee SH, Huang JW, Hung KY, Leu LJ, Kan YT, Yang CS, Chung Wu D, Huang CL, Chen PY, Chen JS, Chen WY.
    Artif Organs; 2000 Nov 15; 24(11):841-4. PubMed ID: 11119069
    [Abstract] [Full Text] [Related]

  • 15. Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study.
    Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D, Alberta Kidney Disease Network.
    Am J Kidney Dis; 2017 Nov 15; 70(5):696-704. PubMed ID: 28838766
    [Abstract] [Full Text] [Related]

  • 16. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H, Mimura T, Honda N.
    Hemodial Int; 2008 Oct 15; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [Abstract] [Full Text] [Related]

  • 17. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J, Galajda P, Ivanková J, Hollý P, Rozborilová E, Kubisz P.
    Clin Appl Thromb Hemost; 2007 Oct 15; 13(4):410-5. PubMed ID: 17911193
    [Abstract] [Full Text] [Related]

  • 18. Trace elements and lipid peroxidation in uremic patients on hemodialysis.
    Lin TH, Chen JG, Liaw JM, Juang JG.
    Biol Trace Elem Res; 1996 Mar 15; 51(3):277-83. PubMed ID: 8727675
    [Abstract] [Full Text] [Related]

  • 19. [Level of zinc, copper, selenium and nickel in serum of patients treated for chronic renal failure with hemodialysis--influence of erythropoietin therapy].
    Kamińska-Galwas B, Grzeszczak W, Jedryczko A, Pachelski J.
    Pol Arch Med Wewn; 1993 May 15; 89(5):368-76. PubMed ID: 8367370
    [Abstract] [Full Text] [Related]

  • 20. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT, Lubrano R, Meloni C, Morosetti M, Manca di Villahermosa S, Scoppi P, Palombo G, Castello MA, Casciani CU.
    Clin Nephrol; 1999 Oct 15; 52(4):239-45. PubMed ID: 10543326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.